Navigation Links
Gentiva Reports Strong Second Quarter led by Home Health Segment
Date:7/31/2008

Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 30, 2007.

Financial and Investor Contact: John R. Potapchuk

631-501-7035

john.potapchuk@gentiva.com

Media Contacts: David Fluhrer

631-501-7102, 516-589-0778

david.fluhrer@gentiva.com


'/>"/>
SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. United Therapeutics Reports Second Quarter 2008 Financial Results
2. The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
3. Neurocrine Biosciences Reports Second Quarter 2008 Results
4. Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
5. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
6. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
8. Cepheid Reports Second Quarter Revenue of $42.1 Million
9. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
10. Lilly Reports Solid Second-Quarter Results
11. Sangamo BioSciences Reports Second Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...st people would like to be able to charge their ce...nd not too often. A recent discovery made by UC Sa...sed supercapacitors that could do just this. , ...Letters , Prabhakar Bandaru, a professor in the UC...ing, along with graduate student Mark Hoefer, have...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)... , ,, BETHESDA, Md., Nov. 19 /PRNewswir...X ), an innovator in biotechnology for diabetes th...consulting services to food, supplement, biotechno... it closed the previously reported $6.3 million re...rs of 2,760,870 shares of its common stock and war...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...ny Promega announced on Tuesday a settlement of a ... had been pending before the U.S. District Court i...Promega will hold a worldwide non-exclusive licens...based around Benitec,s DNA-directed RNA interferen...a combined payment of cash and continued royalties...
...ailer Menards has selected a series of technolog...., the company said Wednesday. , ,Menards deploye...ions software and the Teradata Retail Logical Date...ta marts that could not provide the information bu...ccurate or out-of-date information, according to t...
...of Wisconsin has received a five-year, $1 million ...sthetics protect the human heart against injury fr...g during heart surgery. The college also has recei...ies. , ,Zeljko Bosnjak, Ph.D., professor and vice ...logy, is the principal investigator. , ,A team of ...
Other Biology Technology:
(Date:11/20/2009)... , (Washington, DC Nov. 20, 2009) Scientists fr...hysics sections of the Naval Research Laboratory (...vernment scientists on an Arctic expedition to ini...Sea and determine the spatial variation of sedimen...zing the U.S. Coast Guard Cutter Polar Sea as a re...
(Date:11/20/2009)... , , Toxic dust: Toxins in coal-tar-based seal...inated house dust, according to a USGS study. PAH...molecules found in oil, coal and tar deposits, and... PAHs are often found in house dust; however, the ...mined. Researchers found that dust from indoor are...
(Date:11/20/2009)... This release is available in German . , ...nical Investigation , Dr. Stefanie Eyerich and Dr....m Imperial College London and Istituto Dermopatico...king discovery. It represents a milestone on the w...atory skin diseases such as psoriasis and allergic...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2The Top 10 Business Mistakes Made By Physician Practices 60292 1The Top 10 Business Mistakes Made By Physician Practices 60292 2Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 1Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 2Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 3Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 1Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 2
...clerosis (MS), neuroradiologists and neurologists ...urg have been able to visualize inflammatory tissu...up to now, with the aid of a new contrast medium, ... scientists have published their results in the on...n . , In particular at the early stage of the di...
...ers report this week that chronic exposure to estr...ome cognitive functions. Rats exposed to a steady ... working memory and response inhibition, the resea... the journal Behavioral Neuroscience . , The res...cts of estradiol on activities mediated by the pre...
...covers New Fraud Behavior Patterns, SAN DIEGO, Ju...d identity intelligence, today released the result...which provides an unprecedented,analysis of the cr...e of,identities stolen from the workplace by emplo...nderstanding of the harm resulting from an interna...
Other Biology News:Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2Chronic exposure to estrogen impairs some cognitive functions 2Chronic exposure to estrogen impairs some cognitive functions 3ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 2ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 3ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 4
Mouse Anti-PPP4C Polyclonal Antibody, Unconjugated from Abnova Corporation
...rs maximum application versatility for sample prep...g. Its active heating/cooling function has greatly...ranges. Five different thermoblocks, which can eac...or: 0.5 ml, 1.5 ml, and 2.0 ml volumes; microplate...
Mouse Anti-Human PDE2A Monoclonal Antibody, Unconjugated, Clone 4F4 from Abnova Corporation
...reactivity of an antibody against various proteins...nts or antigen carriers. The array contains spots ...llulose membrane. Application: Determination of an... of purified antibodies, selection of suitable blo...
Biology Products: